RK

Ravi Kumar Pandey

Active Director Director DIN 06584825
DIN 06584825 First appointment May 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2013
Shareholding value •••• Premium profile

About Ravi Kumar Pandey

Data last updated:

Ravi Kumar Pandey is a Director at Aimcad Biotech Private Limited (since 2013). The company operates in Pharma. Aimcad Biotech Private Limited reported revenue of ₹4.69 Cr (FY 2024).

DIN 06584825
Primary Designation Director
Industry Pharma
First Appointment 27 May 2013
Oldest Company Age 13 yrs
Largest company Aimcad Biotech Private Limited · ₹4.69 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aimcad Biotech Private Limited U74120MH2013PTC272456
Director27 May 20132013₹4.69 Cr (FY 2024)Active

Board colleagues of Ravi Kumar Pandey

Directorship timeline

Open interactive timeline →
Aimcad Biotech Private Limited
Premium access

Shareholding and investment profile for Ravi Kumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Kumar Pandey

Ravi Kumar Pandey currently holds 1 directorship: Aimcad Biotech Private Limited (Director, since 27 May 2013, revenue ₹4.69 Cr (FY 2024)).

Ravi Kumar Pandey was first appointed on 27 May 2013 as Director at Aimcad Biotech Private Limited.

The current boards of Ravi Kumar Pandey's companies include Priyanka Keshari (Aimcad Biotech Private Limited), Ruby Pandey (Aimcad Biotech Private Limited), Shyam Kumar Keshari (Aimcad Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available